Kyoto, Japan

Masaki Fujishima

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Powerful Healthy Food Corporation, Sun Chlorella Corp., Other. Active years: 2016.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Masaki Fujishima

Introduction

Masaki Fujishima is a notable inventor based in Kyoto, Japan. He is recognized for his significant contributions to the field of medical science, particularly in the area of angiogenesis inhibition. His innovative approach has the potential to impact various therapeutic applications.

Latest Patents

Fujishima holds a patent for a method of inhibiting angiogenesis. This method involves applying a specific protein polysaccharide derived from a (1→6)-β-D-glucan obtained from the residue of extraction of crushed dried fruiting bodies of Murill (himematsutake) using an 80% ethanol aqueous solution and hot water at 100 degrees Celsius. This patent showcases his dedication to advancing medical research and treatment options.

Career Highlights

Throughout his career, Fujishima has worked with various organizations, including Powerful Healthy Food Corporation. His work has been instrumental in exploring the health benefits of natural compounds and their applications in medicine.

Collaborations

Fujishima has collaborated with notable individuals in his field, including Hitoshi Ito and Hiroko Itoh. These partnerships have contributed to the development of innovative solutions in health and nutrition.

Conclusion

Masaki Fujishima's work exemplifies the spirit of innovation in the medical field. His patent on inhibiting angiogenesis highlights the importance of research in developing new therapeutic methods. His contributions continue to inspire future advancements in health science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…